Data-Driven Decision Making

A new survey finds most mothers reject the 'routine' label, feeling strong in daily acts. One FemTech firm is now championing a shift from sacrifice to celebration.

A new partnership integrates AI planning with trusted measurement, aiming to streamline OOH advertising and deliver unparalleled ROI for brands in the US.

The financial research firm posted a net loss but saw Billings and subscribers grow, signaling a bold strategy of investing in the future.

A free virtual summit unites 20+ experts to share science-based strategies, blending traditional and lifestyle medicine to fight preventable blindness.

The diagnostics firm's stellar quarter is fueled by surging test volumes and a new non-invasive prenatal test poised to disrupt high-risk screening.

Beyond pork, Niman Ranch debuts a steakhouse-quality beef bacon, tapping into sustainable farming and the growing demand for 'Purposeful Protein.'

With its rateIQ platform gaining traction, VIP Software hires a seasoned revenue leader to build a growth engine and pursue its 'Bloomberg for insurance' vision.

BioAdaptives completes its MyndSystem™ with a new nighttime nootropic, aiming to capture the overlooked market for overnight brain recovery.

AppsFlyer expands its Signal Hub with major data partners, offering marketers a privacy-safe arsenal of purchase and identity data to combat signal loss.

A major expansion of the Water-AI Nexus brings tech giants and water experts together to solve a critical paradox: AI's water use vs. its potential.

The legacy sauce brand's #FlavorsofAAPI campaign moves beyond product, using chef stories and strategic partnerships to celebrate AAPI heritage and identity.

A new 'Buy' rating from a major bank subsidiary shines a light on SMAIO's data-driven approach to complex spine surgery. Here's why investors are noticing.

The City of San Marcos partners with Stanbridge University on the Blue Zones Ignite™ initiative, aiming to transform community health from the ground up.

Creatv Bio will present data at ASCO 2026 on its LifeTracDx® blood test, showcasing its potential to personalize cancer treatment through key pharma partnerships.

A new partnership moves AI from isolated tasks to integrated workflows, promising to solve the ROI problem that has plagued enterprise adoption.

As Ricardé Paris claims to lead a 'Quiet Luxury' revival, the market sends mixed signals. Is understated elegance the future or a fading trend?

A new FDA-cleared system offers hope against postpartum hemorrhage, the leading cause of maternal death, earning its maker a prestigious Edison Award.

A new partnership aims to end the 'black box' era of crypto market making, forcing a shift from reputation to verifiable, data-driven performance.

A breakthrough study validates a low-cost blood test that can detect multiple cancers and liver diseases, poised to transform preventative healthcare.

A new 'dream team' of experts will guide AI development to create non-invasive tools for a deadly lung disease, aiming to replace painful procedures.